Baring Private Equity Asia Announces Deal to Sell Lumenis' Surgical Business to Boston Scientific

Posted By American Med Spa Association, Thursday, March 4, 2021

Baring Private Equity Asia (BPEA) and Lumenis announced today that they have entered into a definitive agreement to sell the Lumenis Surgical Business to Boston Scientific in a transaction valued at $1.07 billion, subject to closing adjustments. The Surgical Business includes laser and fibers solutions for minimally invasive surgical procedures in urology and ENT.
Lumenis' high-growth Aesthetics and Vision businesses will continue to operate under BPEA ownership. This strategic sale of the Surgical Business will enable Lumenis to accelerate investment in both domains—in R&D, in global sales and marketing channels, as well as in business development initiatives.
Read more at PR Newswire >>